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Introduction 
La dépression majeure est fréquente chez les patients qui consultent un cabinet de 
médecine générale. Elle reste toutefois difficile à diagnostiquer car elle est souvent masquée 
par une ou plusieurs plaintes physiques qui sont l'unique motif de consultation. Pour aider le 
médecin généraliste à démasquer ce trouble, un test de dépistage composé de deux 
questions a été développé et validé. Ce test indique une probabilité accrue de dépression si 
le patient répond positivement à au moins une des deux questions suivantes : « Est-ce que, 
durant le mois qui a précédé, vous vous êtes senti(e) triste, déprimé(e), désespéré(e)? » et 
« Durant le mois qui a précédé, avez-vous ressenti un manque d'intérêt et de plaisir dans la 
plupart des activités que d'habitude vous appréciez? ». Une troisième question, ajoutée aux 
deux questions ci-dessus, a été proposée récemment afin d'améliorer les performances de 
ce test de dépistage. Cette troisième question rend le test négatif si le patient répond 
négativement à la question suivante : « Souhaitez-vous de l'aide pour cela ? ». Une étude 
avait indiqué que l'ajout de la question supplémentaire améliorait la spécificité du test sans 
réduire sa sensibilité. 
Objectifs 
Il s'agissait de décrire la performance de deux tests· de dépistage de la dépression majeure, 
composés, respectivement, de deux et de trois questions, dans une population de patients 
consultant dans un cabinet de médecine générale pour une plainte physique, et de les 
valider. 
Méthode 
Les réponses aux questions des tests de dépistage de la dépression dans la population de la 
cohorte SODA (Somatisation, Depression, Anxiety) ont été utilisées. Il s'agissait de patients 
de plus de 18 ans, sélectionnés aléatoirement, consultant pour au moins une plainte 
physique auprès de 24 médecins généralistes de Suisse Romande, réexaminés une année 
après l'inclusion dans la cohorte. Le questionnaire validé « Full Patient Health 
Questionnaire » a été utilisé, le même jour, pour diagnostiquer une dépression majeure. Ce 
résultat a été utilisé pour évaluer les performances des deux tests de dépistage en calculant 
la sensibilité et la spécificité, notamment. 
Résultats 
Les données de 724 / 937 patients inclus ont pu être utilisées. Un diagnostic de dépression 
majeure a été posé chez 9.5% des patients (n = 69). La sensibilité et la spécificité des deux 
questions de dépistage étaient de 91.3% (IC9501o : 81.4-96.4%) et 65.0% (IC95% : 61.2-68.6%), 
respectivement. En ajoutant la troisième question, la sensibilité des deux questions de 
dépistage a diminué à 59.4% (1Ces%: 47.0-70.9%) et la spécificité a augmenté à 88.2% 
(1Ces% : 85.4-90.5%). 
Conclusions 
L'utilisation des deux questions pour le dépistage de la dépression majeure est associée à 
une haute sensibilité et à une basse spécificité chez des patients se présentant en cabinet 
de médecine générale pour une plainte physique. En ajoutant la troisième question, la 
spécificité augmente, mais la sensibilité diminue. Ainsi, en ajoutant la troisième question, 
quatre patients dépressifs majeurs sur dix ne sont pas détectés, alors que seulement un 
patient sur dix n'est pas détecté avec les deux questions de dépistage. Notre étude montre 
que le test composé de deux questions reste une méthode de choix pour le dépistage de la 
dépression majeure et que l'ajout de la troisième question n'est pas recommandée. Celle-ci 
reste toutefois pertinente dans l'incitation au dialogue sur le sujet de la dépression entre le 
médecin et son patient. 
Lombardo et al. BMC Medicine 2011, 9:114 
http://www.biomedcentral.com/1741-7015/9/114 
BMC Medicine 
The 'help' question doesn't help when screening 
for major depression: external validation of the 
three-question screening test for primary care 
patients managed for physical complaints 
Patrick Lombardo1, Paul Vaucher1, Nader Haftgoli 1, Bernard Burnand2, Bernard Favrat3, François Verdon\ 
Thomas Bischoff1 and Lilli Herzig 1* 
Abstract 
Background: Major depression, although frequent in primary care, is commonly hidden behind multiple physical 
complaints that are often the first and only reason for patient consultation. Major depression can be screened by two 
validated questions that are easier to use in primary care than the full Diagnostic and Statistical Manua! of Mental 
Disorders, fourth edition (DSM-JV) criteria. A third question, called the 'help' question, improves the specificity without 
apparently decreasing the sensitivity of this screening procedure. We validated the abbreviated screening procedure for 
major depression with and without the 'help' question in primary care patients managed for a physical complaint. 
Methods: This diagnostic accuracy study used data from the SODA (for 'Somatisation Depression Anxiety') cohort 
study conducted by 24 general practitioners (GPs) in western Switzerland that included° patients over 18 years of age 
with at least a single physical complaint at index consultation. Major depression was identified with the full Patient 
Health Questionnaire. GPs were asked to screen patients for major depression with the three screening questions 
1 year after inclusion. 
Results: Of 937 patients with at least a single physical complaint, 751 were eligible 1 year after index consultation. 
Major depression was diagnosed in 69/724 (9.5%) patients. The sensitivity and specificity of the two-question method 
alone were 91.3% (95% Cl 81.4 to 96.4) and 65.0% (95% Ci 61.2 to 68.6), respectively. Adding the 'help' question 
decreased the sensitivity (59.4%; 95% Cl 47.0 to 70.9) but improved the specificity (88.2%; 95% Cl 85.4 to 90.5) of the 
three-question method. 
Conclusions: The use of two screening questions for major depression was associated with high sensitivity and 
low specificity in primary care patients presenting a physical complaint. Adding the 'help' question improved the 
specificity but clearly decreased the sensitivity; when using the 'help' question, four out of ten patients with 
depression will be missed, compared to only one out of ten with the two-question method. Therefore, the 'help' 
question is not useful as a screening question, but may help discussing management strategies. 
Background 
Major depression is found in 3.9% of the general popula-
tion in Europe [1] and a prevalence of 5% to 14% has 
been reported in primary care patients [2-6]. In a more 
recent meta-analysis the rate of depression was even of 
17% to 19% [7]. However, major depression is commonly 
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\ 
hidden behind multiple and sometimes unexplained phy-
sical complaints that are often the first and only reason 
for patients to request consultation [8-12]. Detecting 
mental disorders in the presence of such complaints is 
thus an important challenge for general practitioners 
(GPs) [13]. To help GPs detect major depression, a 
screening tool containing two questions has been derived 
from the Diagnostic and Statistical Manual of Mental 
Disorders, fourth edition (DSM-IV) criteria and validated 
© 2011 Lombardo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative 
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited. 
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[14]. These questions are simple, respectful, easy to inte-
grate into the consultation, and require less time than the 
full DSM-IV criteria. Arroll et al. [15,16] suggested the 
addition of a third question called the 'help' question, in 
which the patient is asked whether they would like help 
regarding the issues raised by the first two screening 
questions. This new screening tool was reported to result 
in increased specificity (from 67% to 89%) not accompa-
nied by decreased sensitivity (from 97% to 96%). In gen-
eral, the addition of a mandatory qualifying question to a 
screening tool usually decreases the sensitivity and 
increases the specificity of the test, unless the added 
question is perfectly discriminatory. 
Since most primary care patients are usually followed by 
their GP for many years, we conducted a navel investiga-
tion into the utility of these screening procedures over 
time. We examined the contribution to diagnosis of the 
two screening questions and the additional 'help' question 
in patients previously seen by a GP for a physical com-
plaint (index consultation) and followed-up for a year. The 
accuracies of the two-question and three-question screen-
ing methods were explored across subgroups defined by 
age, gender, education level, migration status, presence of 
other mental disorders (anxiety, somatoform disorder, 
alcohol abuse), and presentation of major or minor 
depression at the time of index consultation. 
Methods 
This diagnostic accuracy study was nested within a larger 
cohort study on the occurrence and correlations of depres-
sion, anxiety, and somatoform disorders (the SODA (for 
'SOmatisation Depression Anxiety') cohort study [17)) in 
primary care patients with physical complaints who were 
followed over 1 year. Data were collected in western 
French-speaking Switzerland by 21 GPs in private practice 
and 3 medical doctor (MD) trainees from 1 academic pri-
mary care centre from November 2004 to March 2007. 
This study protocol was approved by the State Ethics 
Committee of the Canton of Vaud (Prot.100/04). 
Patients and follow-up 
This study, conducted 1 year after the index consultation, 
included consenting patients aged 18 years and over who 
presented with at least 1 physical complaint during the 
index consultation at 1 of 22 recruiting centres. Patients 
with vital emergencies, dementia, intellectual deficiency, 
inability to understand French, or acute psychiatrie dis-
eases that prevented the patient from answering appropri-
ately were excluded. The GPs included one patient per 
each half-day of consultation. To minimise selection bias, 
patients eligible for inclusion were selected by each GP 
using a pre-established, daily, randomised rank order list, 
thus defining each eligible patient for every half-day. In 
the academic primary care centre all eligible patients were 
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enrolled (MD trainees see fewer patients) nevertheless 
more patients could not be included, mainly due to lan-
guage barriers. GPs completed a case report form for each 
patient. Each patient received a self-administered ques-
tionnaire that was either to be completed in the waiting 
room or returned by mail in the next few days. Patients 
were followed-up by their GPs as needed according to 
usual practice. The 1-year follow-up consultation took 
place during a scheduled visit 9-15 months after the index 
consultation. Patients who did not consult their physicians 
spontaneously during the 1-year follow-up were invited by 
phone to plan a visit within the next 3 months. Data col-
lected during the follow-up consultation allowed the 
assessment of the accuracy of the screening questions in 
detecting major depression. 
The participating primary care physicians were all 
trained in family practice or general internai medicine and 
worked in primary care settings. These physicians were 
trained in the use of the three screening questions for 
major depression. GPs were allowed to investigate depres-
sion only after they asked the three screening questions. 
Physicians were blinded to the reference standard results 
of bath the initial and follow-up consultations, but were 
not necessarily blinded to the patient's depression status. 
Questionnaires 
During the index and follow-up consultations, GPs read 
out the two screening questions for major depression: 
'During the past month have you often been bothered by 
feeling down, depressed, or hopeless?' and 'During the 
past month have you often been bothered by little interest 
or pleasure in doing things?'. Patients responding posi-
tively to either of these questions were asked the 'help' 
question: 'Is this something with which you would like 
help?' with three possible responses: 'no', 'yes, but not 
today', or 'yes'. These three screening questions were 
translated from English to French and then reverse trans-
lated. Patients responding positively to either of the first 
two questions were considered 'positive' for the two 
screening questions. Patients who responded positively to 
either of the two questions and to the 'help' question ('yes' 
or 'yes, but not today') were considered 'positive' for the 
three screening questions. All other patients were consid-
ered 'negative'. 
After the consultation, the patients independently com-
pleted the reference standard questionnaire (full Patient 
Health Questionnaire (PHQ)) [3,18,19], a validated French 
version of the self-reported Primary Care Evaluation of 
Mental Disorders (PRIME-MD) [20] questionnaire. This 
questionnaire was designed to detect mental disorders in 
primary care practice, including depression, anxiety, alco-
hol abuse, and eating and somatoform disorders. To clas-
sify whether patients had major depression, we used nine 
questions corresponding to DSM-IV criteria (questions 2a 
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to 2i) [18]. Patients who responded positively to at least 
one of the first two screening questions and to five or 
more of the nine questions were considered to have major 
depressive syndrome. Minor depression was considered 
present when three or four of the nine questions were 
answered positively and at least one of the two core 
questions. 
Anxiety, somatoform disorder, alcohol abuse and expo-
sure to psychosocial stressors were assessed with PHQ 
questions. Patients were considered to be exposed to a 
psychosocial stressor if they reported being bothered a lot 
by at least one of the ten stressors assessed with question 
12 of the full PHQ [18] (1, health; 2, weight or appearance; 
3, having little or no sexual desire or pleasure during sex; 
4, difficulties with husband/wife, partner/lover or boy-
friend/girlfriend; 5, the stress of taking care of children, 
parents or other family members; 6, stress at work or out-
side of the home or at school; 7, financial problems or 
worries; 8, having no one to turn to when having a pro-
blem; 9, something bad that happened recently; 10, think-
ing or dreaming about something terrible that happened 
in the past). Sociodemographic questions included age, 
gender, and nationality (dichotomised into Swiss or non-
Swiss). Professional education included eight categories 
summarised in a dichotomised variable: presence or 
absence of fully achieved training beyond compulsory 
school. 
Questionnaires were sent to the data centre, and ail vari-
ables were double entered and checked. A researcher, 
blinded to index consultation results, determined which 
patients presented PHQ criteria for major depression. 
Statistical methods 
The sample size necessary to obtain a 10%-wide interval 
around a 70% expected sensitivity (a = 0.05) was calcu-
lated, assuming a 10% prevalence of major depression. 
The expectation of 20% loss to follow-up led to a total of 
947 patients required for inclusion, a figure that was 
rounded to 1,000 patients. 
Sensitivity, specificity, positive and negative likelihoods, 
and predictive values were calculated, with their respective 
95% confidence intervals (95% Cis), to determine screen-
ing test accuracy. Sensitivity, specificity, and 95% Cis were 
also calculated for subpopulations stratified by age, gender, 
nationality, education level, anxiety, somatoform disorder, 
depression status at the index consultation, and exposure 
to a psychosocial stressor. Although these variables were 
predefined before analysis, this study was not sufficiently 
powerful to detect significant clinical differences between 
subgroups. The effects of these factors on the screening 
method were estimated by likelihood ratio test comparing 
logistic regression models with or without an interaction 
term. Characteristics of the patients (age, gender, level of 
education, and depression at index consultation) were 
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compared between patients included and those excluded 
from the analysis to assess potential selection bias. 
Results 
Between November 2004 and July 2005, 937 patients 
were included in the present study. At 1 year after inclu-
sion, 751 patients agreed to be questioned (Figure 1). A 
total of 12 patients did not answer ail PHQ questions, 
making it impossible to know whether they were suffer-
ing from depression, and the physician did not report the 
results of 3 screening questions for 15 other patients. 
Thus, 724 patients were included in the analysis. The 
included patients were similar to those excluded regard-
ing gender (63.3% of women in the group included vs 
62.4%), age of 65 years or over (29.8% vs 25.3%), educa-
tion level (79.9% vs 79.8%), and presence of major 
depression at the index consultation (11.3% vs 14.0%). 
Most patients (91.3%) were recruited from private prac-
tices, with the number of patients from each practice ran-
ging from 6 to 58. Patients were mainly women (63.3%) 
and had a mean age of 54.7 years (SD 17 years). The 
most frequent diagnoses for the main physical complaint 
were musculoskeletal (29.9%) or digestive (8.4%). In 94 
patients (13%), a mental disorder was considered to be 
related to the initial physical complaint. During the year 
of follow-up, 83.1% of patients visited their GP at least 
once, and 40.4% received psychotherapeutic care from 
their GP. Psychotropic drugs were used by 34.2% of the 
patients and 8.1 % were referred to either a psychiatrist or 
a psychologist. At 1 year after the index consultation the 
prevalence of major depression was of 9.5%. 
The depression screening test administered by GPs 
was completed on the same day as the reference test 
(PHQ) by 59.3% and within 1 week by additional 25% of 
patients. Physicians did not report any adverse effects of 
using the three screening questions. GPs did not report 
an answer to the 'help' question in five patients (0.7%). 
The sensitivity and specificity of the two screening 
questions were 91.3% (95% CI 81.4 to 96.4) and 65.0% 
(95% CI 61.2 to 68.6), respectively (Table 1). Adding the 
'help' question improved the specificity to 88.2% (95% CI 
85.4 to 90.5), but the sensitivity decreased to 59.4% (95% 
CI 47.0 to 70.9). In fact, 118 (40.4%) of the patients initi-
ally screened positive for depression (N 292) were willing 
to accept help (Figure 2). Considering the patients who 
were not already being treated for major depression only, 
the sensitivity and the specificity of the two-question 
method are, respectively, 84.6% (95% CI 54.6 to 98.1) and 
76.8% (95% CI 72.0 to 81.2). For the three-question 
method the sensitivity decreased to 46.2% (95% CI 19.2 
to 74.9) and the specificity increased to 94.5% (95% CI 
91.5 to 96.7). 
We next explored the sensitivity and specificity of both 
screening instruments in various patient subpopulations 
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(Table 2). The sensitivity of the two-question method was 
high and consistent through the entire population, ran-
ging from 80% (95% CI 51.3 to 94.6) in patients older 
than 65 years to 100% (95% CI 83.4 to 100) in men. The 
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Al 
Lost at follow-up N=186 
• 10 patients died 
. 44 of them were unreachable 
. 31 CRFs were not completed 
~ by physicians without any 
y 
given explanation 
. 17 refused to answer 
questions at one year 
• 84 Questionnaire was not 
returned by the patient 
"' Missing data N=27 
. 1 Missing questionnaire from 
~ the GP 
. 12 patients with missing data 
for the diagnostic of depresion 
. 14 no response were given 
about the screening questions 
specificity of both screening instruments exhibited 
important disparities across patients with various mental 
states. Patients who suffered from depression at the 
index consultation, who were exposed to a psychosocial 
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Table 1 Sensitivity, specificity, positive/negative predictive values, positive/negative likelihood ratios for major 
depression 
Parameter Two screening questions 
% (95% Cl) 
Sensitivity 91.3% (81.4 to 96.4) 
Specificity 65.0% (61.2 to 68.6) 
Positive predictive value 21.6% (17.1 to 26.8) 
Negative predictive value 98.6% (96.8 to 99.4) 
Positive likelihood ratio 2.6 (2.3 to 3.0) 
Negative likelihood ratio 0.1 (0.06 to 0.28) 
stressor during the 4 previous weeks, or who were diag-
nosed with either anxiety or somatoform disorder were 
more likely to answer positively to each screening instru-
ment without being diagnosed as having depression, as 
indicated by a lower specificity (Table 2). 
Discussion 
In primary care patients well known by their GPs, the 
two-question screening method for major depression dis-
played high sensitivity (91%) and low specificity (65%). As 
suspected, adding the 'help' question led to a decreased 
sensitivity (59%) but a higher specificity (88%). We also 
observed a lower specificity for the two-question and 
three-question methods in subpopulations with other 
psychiatrie conditions (such as generalised anxiety) and 
in patients who had exhibited major depression 1 year 
previously. 
The strengths of our study are its large sample size, the 
number and diversity of the participating GPs, and the 
use of standardised, validated measures for mental disor-
ders. Furthermore, the random selection of patients and 
their recruitment from a large number of GPs in various 
settings decreased the risk of selection bias. W e therefore 
believe that our observations are relevant for most 
patients with physical complaints in primary care in 
developed countries. However, our study is limited 
because the two screening questions for major depression 
were similar to those of the PHQ-9, our reference stan-
dard. Therefore, the sensitivity of the screening method 
is expected to be very high. Finally, the PHQ-9 may not 
be the best reference standard for major depression for 
the following three reasons: (1) it is self-report, (2) it 
doesn't apply exclusion criteria, and (3) it doesn't apply 
clinical significance criteria. Thus PHQ-9 can only be 
interpreted as a proxy of DSM-IV [21,22]. Therefore a 
standardised visit to a psychiatrist would have been 
preferred. 
Whooley et al. [23] and Arroll et al. [24] first intro-
duced the two-question screening method and reported 
high sensitivities (96% and 97%, respectively) and low 
Three screening questions 
% (95% Cl) 
59.4% (47.0 to 70.9) 
88.2% (85.4 to 90.5) 
34.7% (26.4 to 44.1) 
95.3% (93.3 to 96.8) 
5.0 (3.8 to 6.7) 
0.5 (0.3 to 0.6) 
specificities (57% and 67%, respectively). Lowe et al. [25] 
evaluated the two screening questions in outpatients and 
obtained similar results with a dichotomous answer (yes/ 
no). Furthermore, the two-question method was able to 
detect changes in a patient's state of depression. Here we 
report observations similar to those of Arroll et al. [24] 
regarding screening for ma:jor depression with two ques-
tions. The high sensitivity of these questions allows GPs 
to securely rule out negative patients, but the relatively 
low specificity requires further investigations to confi-
dently diagnose major depression in positive cases [14]. 
Introduction of the third 'help' question was a very 
interesting and logical proposition, and should have 
facilitated the diagnosis of major depression. When we 
added the 'help' question to the screening method, how-
ever, our observations were substantially different from 
those of Arroll et al., [15] who reported increased specifi-
city (89%) but identical sensitivity (96%). As an important 
number of their patients with major depression 
responded 'no' to the 'help' question, it is not clear why 
the sensitivity remained identical. In a second study, 
Goodyear et al. [16] validated the two-question and 
three-question methods using the PHQ-9 as a reference 
standard for major depression. Although the two-ques-
tion method was associated with a sensitivity of 98% and 
a specificity of 73%, and the specificity of the three-ques-
tion method questions was reported to be 99%, the sensi-
tivity of the three-question method was not provided. 
A recent publication by the same authors determines a 
sensitivity of 99.2% and a specificity of 70.4% for the two-
question method, whereas the sensitivity decreased to 
87 .1 % and the specificity increased to 94.8% for the 
three-question method [26]. 
An independent study by Baker-Glenn et al. [27] 
observed a sensitivity of 23.7% and specificity 97.8% in 
patients attending chemotherapy with the three-question 
method. We therefore believe Arrol et al.'s [15] results 
to be misleading. These findings support the latest 
NICE [28] guidelines that recommend only the use of 
the two screening questions. 
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Our analysis indicates that although the three-ques-
tion method has high negative predictive value, the high 
false negative rate implies that as many as four patients 
out of ten (28/69) with major depression would not be 
correctly diagnosed with this method. ln comparison, 
less than one out of ten patients (6/69) with major 
depression will not be diagnosed when using the two-
question method. lt is therefore not helpful to include 
Lombardo et al. BMC Medicine 2011, 9:114 
http://www.biomedcentral.com/1741-7015/9/114 
Page 7 of 9 
Table 2 Stratified specificity of screening questions for major depression 
Characteristic Prevalence of 
depression, 
% (95% Cl) 
Ove ra li 9.5% (7.6 to 12.0) 
Gender 
Male 9.4% (6.3 to 13.7) 
Female 9.6% (7.1 to 12.8) 
Age 
< 65 years 10.9% (8.4 to 14.1) 
;,, 65 years 6.4% (3.8 to 10.6) 
Nationality 
Swiss 8.0% (6.0 to 10.6) 
Not Swiss 14.8% (9.4 to 22.5) 
Education level 
Professional training 9.4% (71.5 to 12.3) 
No professional training 9.0% (5.0 to 15.1) 
Psychosocial stressors 
;,, 1 major stressor 21.5% (16.9 to 26.9) 
No major stressor 2.0% (1.0 to 4.0) 
Mood disorders 1 year previously 
Major depression 39.0% (28.6 to 50.4) 
Minar depression 15.0% (7.5 to 27. 1) 
No depression 39. 1 % (25.2 to 59.5) 
Anxiety 
Anxiety syndrome 60.0% (45.2 to 73.2) 
No anxiety 57.1% (41.2 to 78.3) 
Somatoform disorder 
;,, 3 symptoms 31.7% (22. 1 to 43.0) 
< 3 symptoms 6.7% (5.0 to 9.0) 
the third 'help' question to rule out major depression in 
patients well known by their GPs. But as Kroenke [29] 
suggests, 'screening for depression is not enough'. 
Patients identified with depression have to be treated. 
Therefore the 'help' question remains clinically relevant, 
even if more than half of patients with major depression 
did not ask for help. But within the context of the con-
sultation, the 'help' question enables a continuing dis-
cussion about mood disorders and allows evaluation of 
the appropriateness of a psychiatrie treatment and refer-
ral. Baker-Glenn et al. conclude, as we do, that the 
'help' question may highlight patients willing to accept 
support [27]. This also underlines GPs' role in investi-
gating and answering patient expectations for their psy-
chological distress as described by Walters showing that 
patients with milder symptoms usually prefer simple 
human contact, and informal resource rather than for-
mal interventions or medication [30]. While all these 
questions may help GPs screen for major depression in 
their patients, this tool should not replace clinical 
Specificity, % (95% Cl) 
Two screening Three screening 
questions questions 
65.0% (61.2 to 68.6) 88.2% (85.4 to 90.5) 
69.2% (63.0 to 75.0) 90.0% (85.4 to 93.4) 
62.5% (57.7 to 67.2) 87.2% (83.5 to 90.2) 
66.1% (61.4 to 70.5) 87.4% (83.8 to 90.3) 
62.8% (56.0 to 69.2) 89.9% (84.9 to 93.4) 
67.6% (63.3 to 71.5) 89. 1 % (86.0 to 91.5) 
53.2% (43.4 to 62.7) 84.4% (75.9 to 90.4) 
66.8% (62.4 to 70.9) 88.3% (85.1 to 91.0) 
60.6% (51.7 to 68.8) 88.6% (81.7 to 93.3) 
44.3% (37.6 to 51.1) 77.6% (71.4 to 82.8) 
76.0% (71.7 to 79.9) 93.7% (90.9 to 95.7) 
34.0% (21.6 to 48.8) 62.0% (47.1 to 75.0) 
43. 1 % (29.6 to 57.7) 84.3% (70.8 to 92.5) 
70.1% (66.0 to 73.9) 91.1% (88.3 to 93.3) 
5% (0.2 to 26.9) 40.0% (20.0 to 63.6) 
67.1% (63.3 to 70.8) 89.8% (87.1 to 92.0) 
46.4% (33.2 to 60. 1) 67.9% (53.9 to 79.4) 
67.7% (62.7 to 70.4) 90.1% (87.4 to 92.3) 
judgment; indeed, GPs seldom rely on questionnaires 
alone [31,32]. 
Our observations suggest that the sensitivity of the two 
screening questions is consistent across various patient 
subpopulations guaranteeing a low number of false nega-
tives regardless of patient characteristics. However, as the 
specificity differs across patients, GPs may frequently and 
falsely diagnose major depression in patients who present 
other mental disorders. Additional studies are necessary to 
quantify the actual benefits of screening mental disorders 
in primary care with the two-question and three-question 
screening methods. 
Conclusions 
The two-question screening method for major depression 
exhibited a high sensitivity and a low specificity when 
applied to well known primary care patients with a physi-
cal complaint. Adding the 'help' question improved the 
specificity of the test, but clearly decreased its sensitivity: 
four out of ten patients will thus be missed with the 
Lombardo et al. BMC Medicine 2011, 9:114 
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three-question method, compared to only one out of ten 
with the two-question method. Although the 'help' ques-
tion is not useful as a screening question in this patient 
group, it may facilitate discussion about mood disorders 
and its management. 
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